XML 24 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 29, 2014
Mar. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 7,668 $ 5,756
Adjustments to reconcile net earnings attributable to controlling interest:    
Depreciation 7,691 7,140
Amortization of intangibles 586 604
Expense associated with share-based compensation arrangements 495 642
Expense associated with stock grant plans 29 19
Deferred income taxes (credit) (150) 36
Equity in earnings of investee (51) (42)
Net gain on sale of property, plant and equipment (602) (127)
Changes in:    
Accounts receivable (61,825) (70,715)
Inventories (23,980) (47,305)
Accounts payable 18,150 27,417
Accrued liabilities and other (2,743) 12,001
NET CASH FROM OPERATING ACTIVITIES (54,732) (64,574)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (8,994) (8,085)
Proceeds from sale of property, plant and equipment 785 251
Acquisitions, net of cash received (4,191) (8,600)
Advances on notes receivable (2,462) (383)
Collections on notes receivable 473 543
Cash restricted as to use 0 6,178
Other, net (36) 6
NET CASH FROM INVESTING ACTIVITIES (14,425) (10,090)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings under revolving credit facilities 106,318 110,177
Repayments under revolving credit facilities (47,547) (50,786)
Proceeds from issuance of common stock 99 80
Distributions to noncontrolling interest (701) (330)
Other, net (8) (6)
NET CASH FROM FINANCING ACTIVITIES 58,161 59,135
Effect of exchange rate changes on cash (76) 217
NET CHANGE IN CASH AND CASH EQUIVALENTS (11,072) (15,312)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR (1,079) 7,647
CASH (CASH OVERDRAFT), END OF PERIOD (12,151) (7,665)
SUPPLEMENTAL INFORMATION:    
Interest paid 281 417
Income taxes paid (refunded) 1,681 (6,199)
NON-CASH INVESTING ACTIVITIES    
Other receivables exchanged for notes receivable 2,768 0
NON-CASH FINANCING ACTIVITIES:    
Common stock issued under deferred compensation plans $ 1,894 $ 1,329